Search - tctmd.com

Displaying 601 - 620 of 955

Sort: Relevancy | Date

News Daily News

La FA Post-TAVR se Asocia a un Mayor Riesgo de Mortalidad y Hemorragias

Michael O'Riordan

April 18, 2016

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Daily News

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Michael O'Riordan

April 18, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Industry News

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

April 07, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Daily News

接受 TAVR 的年满 90 岁患者死亡风险“临床适度”增加

March 23, 2016

News Daily News

Se Observa un ‘Tímido Aumento Clínico’ del Riesgo de Mortalidad en Nonagenarios sometidos a TAVR

March 23, 2016

Presentation ECHO 2016

Asymptomatic Valvular Heart Disease: Can Echocardiography Help with Decision-Making?

Presenter: Charles J. Bruce

March 22, 2016

News Industry News

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

March 16, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Daily News

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

L.A. McKeown

March 08, 2016

News Daily News

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Shelley Wood

March 07, 2016

News Industry News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

March 07, 2016

News Daily News

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

Todd Neale

March 06, 2016

News Daily News

Un Nuevo Análisis No Halla un Nexo entre una PCI de Éxito en una OTC y una Menor Mortalidad

Todd Neale

March 06, 2016

Advertisement

La FA Post-TAVR se Asocia a un Mayor Riesgo de Mortalidad y Hemorragias

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

接受 TAVR 的年满 90 岁患者死亡风险“临床适度”增加

Se Observa un ‘Tímido Aumento Clínico’ del Riesgo de Mortalidad en Nonagenarios sometidos a TAVR

Asymptomatic Valvular Heart Disease: Can Echocardiography Help with Decision-Making?

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

Un Nuevo Análisis No Halla un Nexo entre una PCI de Éxito en una OTC y una Menor Mortalidad

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content